tirzepatide weight loss colorado springs Program Tirzepatide vs Semaglutide for Weight

Some people have noticed a fishy body odor when consuming 3 grams per day

The BioStation staff also offers a weight-loss program built around semaglutide, a compound approved by the Food and Drug Administration (FDA) in 2021 to help people with chronic weight-management conditions or those who are overweight with one weight-related condition

This dual mechanism sets it apart from single-target GLP-1 receptor agonists like semaglutide

However, there are some conditions that may contraindicate treatment with tirzepatide, such as severe gastrointestinal disease, gastroparesis, and type 1 diabetes

Some people also have a genetic disposition to be overweight

In June 2026 the MHRA approved the Wegovy pill , the first oral GLP-1 medicine licensed in the UK specifically for weight loss